Latest Asx News

4DMedical has secured multi-year agreements to deploy its advanced lung imaging technology across Brazil and Australia, supporting national lung cancer screening programs and enhancing lung health diagnostics.

Proteomics International has unveiled new clinical data confirming its PromarkerEso blood test can accurately detect early stages of esophageal adenocarcinoma, potentially transforming screening for a cancer with poor prognosis.

Hazer Group and First Graphene have signed a non-binding MOU to explore innovative applications for Hazer’s proprietary graphite, aiming to capitalize on rising global demand amid supply constraints.

Pathkey.AI’s TrialKey platform has demonstrated a 73% alignment with actual biotech trial outcomes, showing an average hypothetical share price gain of 76%, underscoring AI’s growing role in clinical trial prediction and biotech investing.

Southern Cross Gold Consolidated Ltd reports exceptional high-grade gold and antimony drill results from its Sunday Creek project in Victoria, revealing significant mineralization extensions both laterally and at depth.

Torque Metals has reported a significant new gold discovery outside the current resource boundary at its Paris Gold Project, highlighting substantial exploration upside. Step-out drilling revealed a 25-metre intercept averaging 3.9 g/t gold, expanding the known mineralised system.

Galileo Mining has reported significant palladium, platinum, and gold assay results from aircore drilling at its Norseman project, defining a 10km continuous PGE anomaly at the Mission Sill prospect. The company is gearing up for follow-up reverse circulation drilling to test for deeper mineralisation.

D3 Energy has submitted its Production Right application for part of its South African ER315 permit well ahead of schedule and under budget, marking a key step toward commercialising certified methane and helium reserves.

Memphasys has inked a five-year exclusive distribution agreement with Middle East leader ITL, unlocking a $325,000 initial order for its Felix™ fertility system upon CE Mark approval. This deal opens access to 15 countries and over 350 IVF clinics, setting the stage for rapid regional adoption.

Elsight has secured a US$5.35 million contract with a European defence OEM, pushing its 2025 orders to US$23.3 million, a staggering 1000% increase over 2024. The company’s rising deliveries and upcoming ASX index inclusions mark a pivotal growth phase.

Critical Resources Limited has completed due diligence on the Cap Burn Gold-Antimony project in New Zealand and is moving forward with acquisition and exploration plans, aiming to start drilling by October or November 2025.

Victory Metals has identified multiple ultra-high heavy rare earth oxide zones at its North Stanmore project, positioning it as a key future supplier amid soaring global prices. The company plans a major drilling campaign to expand these valuable zones while reducing processing volumes and costs.